Federico Massa is an expert in Neurology at Ospedale Policlinico San Martino (Italy). Federico Massa has authored 180 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 528 (community average: 125). How the SLR is computed.

LeadR Profile

528 ScienceLeadR Reputation 528
Network Map

Neurology

Subspecialties: Psychiatry - Nuclear Medicine - Medical Imaging

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

I am a specialist in Neurology, graduated with honors, and earned a Ph.D. in Clinical and Experimental Neuroscience in May 2023. I have obtained the National Scientific Qualification as Associate Professor in the Italian education system for the disciplinary field Neurology. Currently, I serve as a Research Fellow at the Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, and Maternal and Child Health (DINOGMI) of the University of Genoa and as a Consultant Neurologist at the IRCCS Azienda Ospedaliera Metropolitana (AOM) Liguria, San Martino hospital, Genoa (Italy.

Since the early years of my training, I have been deeply engaged in the management of patients with neurodegenerative diseases, particularly dementia, movement disorders, and rare neuroinflammatory conditions, including autoimmune encephalitis. My research spans over 115 publications in international peer-reviewed journals and several monographs in book chapters, with 15 as the first author. I have developed specific expertise in molecular imaging and fluid biomarkers for diagnostic and prognostic purposes, contributing to Italian research groups and international consortia advancing these fields.

With a strong commitment to European healthcare and research collaboration, I actively contribute to the European Academy of Neurology (EAN) panels on cognitive and motor disorders, as well as high cortical functions. I hold the Certificate of Fellowship of the European Board of Neurology (FEBN), and of ‘Advocate for Neurology and Brain Health’ and currently serve as the Guideline Representative for the Dementia and Cognitive Disorders Panel of the EAN, contributing to shaping and implementing clinical guidelines in this domain.

I am an organized, proactive professional with a strong ability to work in multidisciplinary teams while fostering empathetic, clear, and responsible communication with patients. My skill set includes designing and executing research projects, conducting comprehensive data analyses, and critically evaluating findings. Passionate and dedicated, I efficiently manage multiple tasks while ensuring high-quality outcomes and effectively presenting experimental data to diverse audiences.




Organizations

Career arc: 2015 - 2026

Source: PubMed

University of Genoa

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 180

Citations

Citations: 4 976 1st author: 29 Last author: 4 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
T1 mapping in Alzheimer's disease: a quantitative MRI study with amyloid-PET correlation.
PMID 42766053 — gray matter, alzheimer disease, brain, cognitive dysfunction, biomarkers, aged, amyloid
Eur Radiol Exp20260
Toward harmonized reporting of Alzheimer's disease biomarkers in clinical practice.
PMID 42683894 — research design, laboratories, clinical decision-making, alzheimer disease, biomarkers, neurodegenerative diseases
Clin Chem Lab Med20260
Structural MRI signature predicts tau staging in Alzheimer's disease.
PMID 42657236 — atrophy, alzheimer disease, cognitive dysfunction
Alzheimers Dement (Amst)20260
Exploring the spatial covariance of cerebral vascular density and amyloid burden in Alzheimer's disease.
PMID 42326471 — alzheimer disease, amyloid
Alzheimers Dement (Amst)20260
Glymphatic clearance as revealed by diffusion tensor imaging along the perivascular space (DTI-ALPS) is associated with Alzheimer's disease neuropathology and periodic rsEEG alpha rhythms in mild cognitive impairment participants.
PMID 42291616 — alpha rhythm, alzheimer disease, cognitive dysfunction, diffusion tensor imaging, cognition disorders, neuropathology
Alzheimers Dement (Amst)20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 1

By status:

Completed 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map